Insiders · Profile

Versant V Luxco S.a r.l.

10% owner at Aprea Therapeutics. Filing since 7 Oct 2019. CIK 0001786141

Company

Date

Role

Action

Shares

Amount

Of holding

APRE Aprea Therapeutics, Inc.

7 Oct 2019

10% owner

Bought

333,333

$5.00M

opened

1 decision on file.